Zhengye Biotechnology Holding Limited (ZYBT)

Zhengye Biotechnology Holding Limited is a China-based company whose Class A ordinary shares trade on the Nasdaq. Through its operating subsidiaries, the company develops, manufactures and sells veterinary vaccines.

Its products are used to protect livestock and poultry, such as pigs, cattle, sheep and chickens, against infectious diseases, and are sold to farms, distributors and government animal health programs in China. The company is organized as an offshore holding company, a common structure for China-based issuers listed in the United States, and details on its facilities and product approvals appear in its SEC filings.